Literature DB >> 19995708

Concentration of surfactant protein D, Clara cell protein CC-16 and IL-10 in bronchoalveolar lavage (BAL) in patients with sarcoidosis, hypersensivity pneumonitis and idiopathic pulmonary fibrosis.

Wojciech Kucejko1, Elzbieta Chyczewska, Wojciech Naumnik, Maria Ossolińska.   

Abstract

The process of interstitial inflammation, often chronic, goes fluently from alveolitis through granuloma formation to irreversible fibrosis and lung remodeling. Eventually, the loss of functional alveolar units leads to chronic respiratory failure. The pneumoproteins (e.g. SP-D, CC-16) are considered to be markers of interstitial inflammation. We measured BAL concentration of SP-D, CC-16 and IL-10 in patients with sarcoidosis (27), IPF (7) and HP (9). The level of each marker was determined by ELISA specific kit. We found the highest SP-D and CC-16 BAL concentration in patients with the III stage of sarcoidosis (96,67 ng/ml and 31,78 ng/ml, respectively). The lowest SP-D concentration was observed in patients with IPF (76,49 ng/ml), and the lowest CC-16 concentration in patients with HP (21,39 ng/ml). The differences were not statistically significant. In the group of the III stage of sarcoidosis higher SP-D levels were related to higher BAL cytosis and higher percentage of BAL neutrophils, just the opposite as in the IPF and HP group. In the III stage of sarcoidosis and HP, the lower SP-D levels, the lower FEV1 and VC values. The results show, that in acute interstitial inflammation with larger parenchyma engagement (III stage of sarcoidosis) the levels of SP-D were higher then in chronic interstitial inflammation (IPF).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19995708     DOI: 10.2478/v10042-009-0028-9

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  12 in total

1.  Tissue and Bronchoalveolar Lavage Biomarkers in Idiopathic Pulmonary Fibrosis Patients on Pirfenidone.

Authors:  Nicola Ronan; Deirdre M Bennett; Kashif A Khan; Yvonne McCarthy; Darren Dahly; Louise Bourke; Adeline Chelliah; Alberto Cavazza; Kevin O'Regan; Fiachra Moloney; Barry J Plant; Michael T Henry
Journal:  Lung       Date:  2018-07-31       Impact factor: 2.584

Review 2.  Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis.

Authors:  David N O'Dwyer; Shanna L Ashley; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-07-29       Impact factor: 5.464

3.  Effects of leflunomide on inflamation and fibrosis in bleomycine induced pulmonary fibrosis in wistar albino rats.

Authors:  Servet Kayhan; Aygul Guzel; Latif Duran; Serife Tutuncu; Ahmet Guzel; Mithat Gunaydın; Osman Salis; Ali Okuyucu; Mustafa Yasin Selcuk
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

4.  Comparison of lymphocyte immune phenotypes in bronchoalveolar lavage of non-smoking patients with sarcoidosis and other interstitial lung diseases.

Authors:  Eva Novosadova; Zdenka Navratilova; Marta Ordeltova; Monika Zurkova; Jaromir Zatloukal; Vitezslav Kolek; Martin Petrek
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

5.  Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease.

Authors:  Deog Kyeom Kim; Michael H Cho; Craig P Hersh; David A Lomas; Bruce E Miller; Xiangyang Kong; Per Bakke; Amund Gulsvik; Alvar Agustí; Emiel Wouters; Bartolome Celli; Harvey Coxson; Jørgen Vestbo; William MacNee; Julie C Yates; Stephen Rennard; Augusto Litonjua; Weiliang Qiu; Terri H Beaty; James D Crapo; John H Riley; Ruth Tal-Singer; Edwin K Silverman
Journal:  Am J Respir Crit Care Med       Date:  2012-11-09       Impact factor: 21.405

6.  An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive Immunity.

Authors:  Annapurna Nayak; Eswari Dodagatta-Marri; Anthony George Tsolaki; Uday Kishore
Journal:  Front Immunol       Date:  2012-06-07       Impact factor: 7.561

Review 7.  Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family.

Authors:  Erna Sziksz; Domonkos Pap; Rita Lippai; Nóra Judit Béres; Andrea Fekete; Attila J Szabó; Ádám Vannay
Journal:  Mediators Inflamm       Date:  2015-06-24       Impact factor: 4.711

8.  Course of SP-D, YKL-40, CCL18 and CA 15-3 in adult patients hospitalised with community-acquired pneumonia and their association with disease severity and aetiology: A post-hoc analysis.

Authors:  Simone M C Spoorenberg; Stefan M T Vestjens; G P Voorn; Coline H M van Moorsel; Bob Meek; Pieter Zanen; Ger T Rijkers; Willem Jan W Bos; Jan C Grutters
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

9.  Surfactant Protein D modulates HIV infection of both T-cells and dendritic cells.

Authors:  Jens Madsen; Gaurav D Gaiha; Nades Palaniyar; Tao Dong; Daniel A Mitchell; Howard W Clark
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

10.  Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.

Authors:  Ganesh Raghu; Martine Remy-Jardin; Christopher J Ryerson; Jeffrey L Myers; Michael Kreuter; Martina Vasakova; Elena Bargagli; Jonathan H Chung; Bridget F Collins; Elisabeth Bendstrup; Hassan A Chami; Abigail T Chua; Tamera J Corte; Jean-Charles Dalphin; Sonye K Danoff; Javier Diaz-Mendoza; Abhijit Duggal; Ryoko Egashira; Thomas Ewing; Mridu Gulati; Yoshikazu Inoue; Alex R Jenkins; Kerri A Johannson; Takeshi Johkoh; Maximiliano Tamae-Kakazu; Masanori Kitaichi; Shandra L Knight; Dirk Koschel; David J Lederer; Yolanda Mageto; Lisa A Maier; Carlos Matiz; Ferran Morell; Andrew G Nicholson; Setu Patolia; Carlos A Pereira; Elisabetta A Renzoni; Margaret L Salisbury; Moises Selman; Simon L F Walsh; Wim A Wuyts; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 30.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.